獣医腫瘍学の世界市場レポート 2025年

獣医腫瘍学の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.0％で6億9,000万米ドルに成長します。予測期間の成長は、動物のための個別化医療、動物におけるがんの有病率の上昇、老齢化したペット人口の増加、専門的ケアへのアクセス拡大、規制当局のサポートと承認に起因しています。予測期間の主な動向には、高度診断技術、個別化治療アプローチ、免疫療法の進歩、標的療法、腫瘍学診察における遠隔医療などが含まれます。

ペットにおけるがんの有病率の上昇は、今後の獣医腫瘍学市場の成長を大きく促進すると予測されます。がんは、体の他の部分に広がる可能性のある制御不能な細胞増殖を特徴とする病態であり、ペットの場合、腫瘍や腫れなどの身体症状として現れることが多いです。獣医腫瘍学は、動物のがんの診断と治療に注力し、転移や病気の広がりを抑えることを目指しています。その結果、ペットのがん患者の増加が獣医腫瘍学のサービスに対する需要を高めると予想されます。例えば、米国を拠点とするがん研究専門誌Cancer Letterによると、2024年には米国で600万頭の愛犬ががんと診断されると推定されています。さらに、英国を拠点とする獣医団体、英国小動物獣医協会（BSAVA）のデータによると、2023年11月、犬の約4頭に1頭、猫の約5頭に1頭が生涯のうちにがんと診断されるといいます。このように、ペットのがん罹患率の増加が獣医腫瘍学市場を牽引しています。

ペットの養子縁組の増加は、今後数年間で獣医腫瘍学市場を大きく押し上げると予測されています。ペットの養子縁組には、合法的に動物を家に迎え入れ、世話、保護、交友を提供することが含まれます。ペットの飼い主は、ペットの健康と幸福への献身に突き動かされ、予防ヘルスケアやがん診断・治療を含む医療治療を求める傾向が強いです。例えば、英国を拠点とするUK Pet Food Organizationによると、2024年の英国における犬の飼育頭数は1,350万頭、猫の飼育頭数は1,250万頭で、それぞれ150万頭ずつ増加しています。したがって、ペット飼育の動向は獣医腫瘍学市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界獣医腫瘍学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の獣医腫瘍学市場：成長率分析
• 世界の獣医腫瘍学市場の実績：規模と成長, 2019-2024
• 世界の獣医腫瘍学市場の予測：規模と成長, 2024-2029, 2034F
• 世界獣医腫瘍学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の獣医腫瘍学市場：セラピー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術
• 放射線科
• 化学療法
• その他の治療法
• 世界の獣医腫瘍学市場動物の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 馬
• 犬歯
• ネコ科
• その他の動物の種類
• 世界の獣医腫瘍学市場がんの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リンパ腫
• 肥満細胞がん
• 乳腺がんおよび扁平上皮がん
• その他のがんの種類
• 世界の獣医腫瘍学市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍切除
• 緩和手術
• 腹腔鏡手術
• 切断
• 世界の獣医腫瘍学市場、放射線科のサブセグメンテーション、種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 放射線治療
• 定位放射線手術
• 近接放射線療法
• 画像技術
• 世界の獣医腫瘍学市場化学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射化学療法
• 経口化学療法
• 併用化学療法プロトコル
• 標的治療薬
• 世界の獣医腫瘍学市場その他の治療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫療法
• 光線力学療法
• 支持療法
• 代替療法

第7章 地域別・国別分析

• 世界の獣医腫瘍学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の獣医腫瘍学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医腫瘍学市場：競合情勢
• 獣医腫瘍学市場：企業プロファイル
  • PetCure Oncology Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Karyopharm Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Accuray Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boehringer Ingelheim International GmbH
• Elanco Animal Health Inc.
• One Health Company Inc.
• Regeneus Limited
• VetDC Inc.
• Pharmaust Limited
• AdvaVet Inc.
• Nippon Zenyaku Kogyo Company Limited
• Rhizen Pharmaceutical SA
• AB Science SAS
• Siemens Healthineers AG
• Varian Medical Systems
• Pfizer Inc.
• Takis Biotech GmbH
• Qbiotics LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 獣医腫瘍学市場2029：新たな機会を提供する国
• 獣医腫瘍学市場2029：新たな機会を提供するセグメント
• 獣医腫瘍学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary oncology involves the specialized diagnosis and treatment of cancer in animals, aiming to integrate cancer therapies while maintaining the overall quality of life for the affected animals. This field focuses on providing cancer medicine and treatment services tailored to the unique needs of animals.

The primary types of therapies in veterinary oncology include surgery, radiology, chemotherapy, and other specialized treatments. Surgery involves procedures to either remove or repair affected body parts or to assess the presence of disease. A diverse range of animals, including equines, canines, felines, and other species, are involved in veterinary oncology. The field encompasses various cancer types such as lymphomas, mast cell cancer, mammary cancer, squamous cell cancer, among others, specific to different animal species.

The veterinary oncology market research report is one of a series of new reports from The Business Research Company that provides veterinary oncology market statistics, including veterinary oncology industry global market size, regional shares, competitors with veterinary oncology market share, detailed veterinary oncology market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary oncology industry. This veterinary oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.4 billion in 2024 to $0.45 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing pet ownership, humanization of pets, knowledge transfer from human oncology, increasing awareness of pet health, and pharmaceutical developments.

The veterinary oncology market size is expected to see rapid growth in the next few years. It will grow to $0.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to personalized medicine for animals, rising prevalence of cancer in animals, growing geriatric pet population, expanded access to specialized care, regulatory support and approvals. Major trends in the forecast period include advanced diagnostic technologies, personalized treatment approaches, immunotherapy advancements, targeted therapies, telemedicine in oncology consultations.

The rising prevalence of cancer in pets is anticipated to significantly drive the growth of the veterinary oncology market in the future. Cancer is a condition characterized by uncontrolled cell growth that can spread to other parts of the body, and in pets, it often presents as physical symptoms like tumors or swelling. Veterinary oncology focuses on diagnosing and treating cancer in animals, aiming to reduce metastasis and the spread of the disease. Consequently, an increase in pet cancer cases is expected to elevate the demand for veterinary oncology services. For instance, according to the Cancer Letter, a US-based publication dedicated to cancer research, an estimated 6 million pet dogs will be diagnosed with cancer in the United States in 2024. Additionally, data from the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary organization, indicated in November 2023 that approximately 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer during their lifetime. Thus, the increasing prevalence of cancer in pets is driving the veterinary oncology market forward.

The increasing adoption of pets is projected to significantly boost the veterinary oncology market in the coming years. Pet adoption involves legally bringing an animal into one's home and providing care, shelter, and companionship. Pet owners, motivated by a dedication to their pets' health and well-being, are more inclined to pursue preventive healthcare and medical treatments, including cancer diagnostics and therapies. For example, according to the UK Pet Food Organization, a UK-based entity, there are 13.5 million dogs and 12.5 million cats in the UK in 2024, representing an increase of 1.5 million for each species. Therefore, the growing trend of pet adoption is contributing to the expansion of the veterinary oncology market.

Leading companies in the veterinary oncology market are concentrating on developing neoantigens, which are unique tumor-specific antigens resulting from mutations in cancer cells. Neoantigens are distinct protein fragments produced by tumor-specific mutations, differentiating them from normal antigens found in healthy tissues. These proteins arise from genetic alterations (mutations) in the tumor's DNA. For example, in October 2024, a US-based biotechnology company launched a cancer vaccine trial for dogs. The exploration of neoantigens is central to the development of cancer vaccines and other forms of immunotherapy, aiming to enhance the immune response specifically against cancer cells while minimizing the impact on normal cells.

Major players are strategically forging partnerships and collaborations with startups and mid-sized entities in the veterinary oncology market to diversify their offerings. These alliances serve as catalysts for portfolio expansion and geographical outreach. A pertinent example is the strategic partnership between Thrive Pet Healthcare and FidoCure initiated in June 2022. This collaboration endeavors to redefine veterinary cancer care by leveraging FidoCure's cutting-edge precision medicine platform and diagnostic algorithms across Thrive Pet Healthcare's extensive network of over 350 veterinary care clinics, aiming to enhance outcomes for pets diagnosed with cancer.

In July 2022, Zomedica Corp., a veterinary health company based in the US specializing in diagnostic and therapeutic products, completed the acquisition of Assisi Animal Health LLC for an undisclosed sum. This strategic acquisition aims to synergize resources between Zomedica and Assisi, empowering Zomedica to fortify and broaden its product offerings, ultimately providing advanced solutions to elevate companion animal care. Assisi Animal Health LLC, also based in the US, focuses on offering drug-free devices utilizing targeted pulsed electromagnetic field (tPEMF) technology, specifically used for reducing inflammation and treating cancer in dogs.

Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Sante Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

Asia-Pacific was the largest region in the veterinary oncology market in 2024. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary oncology market includes revenues earned by entities by providing cryosurgery, comprehensive care, immunotherapy, and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy: Surgery; Radiology; Chemotherapy; Other Therapies
• 2) By Animal Type: Equine; Canine; Feline; Other Animal Types
• 3) By Cancer Type: Lymphoma; Mast Cell Cancer; Mammary And Squamous Cell Cancer; Other Cancer Types
• Subsegments:
• 1) By Surgery: Tumor Resection; Palliative Surgery; Laparoscopic Surgery; Amputation
• 2) By Radiology: Radiation Therapy; Stereotactic Radiosurgery; Brachytherapy; Imaging Techniques
• 3) By Chemotherapy: Injectable Chemotherapy; Oral Chemotherapy; Combination Chemotherapy Protocols; Targeted Therapy Agents
• 4) By Other Therapies: Immunotherapy; Photodynamic Therapy; Supportive Care; Alternative Therapies
• Companies Mentioned: PetCure Oncology Inc.; Zoetis Inc.; Karyopharm Therapeutics Inc.; Varian Medical Systems Inc.; Accuray Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Oncology Market Characteristics

3. Veterinary Oncology Market Trends And Strategies

4. Veterinary Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Veterinary Oncology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Oncology Market Growth Rate Analysis
• 5.4. Global Veterinary Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Oncology Total Addressable Market (TAM)

6. Veterinary Oncology Market Segmentation

• 6.1. Global Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiology
• Chemotherapy
• Other Therapies
• 6.2. Global Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Equine
• Canine
• Feline
• Other Animal Types
• 6.3. Global Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lymphoma
• Mast Cell Cancer
• Mammary And Squamous Cell Cancer
• Other Cancer Types
• 6.4. Global Veterinary Oncology Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Resection
• Palliative Surgery
• Laparoscopic Surgery
• Amputation
• 6.5. Global Veterinary Oncology Market, Sub-Segmentation Of Radiology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiation Therapy
• Stereotactic Radiosurgery
• Brachytherapy
• Imaging Techniques
• 6.6. Global Veterinary Oncology Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Chemotherapy
• Oral Chemotherapy
• Combination Chemotherapy Protocols
• Targeted Therapy Agents
• 6.7. Global Veterinary Oncology Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunotherapy
• Photodynamic Therapy
• Supportive Care
• Alternative Therapies

7. Veterinary Oncology Market Regional And Country Analysis

• 7.1. Global Veterinary Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Oncology Market

• 8.1. Asia-Pacific Veterinary Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Oncology Market

• 9.1. China Veterinary Oncology Market Overview
• 9.2. China Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Oncology Market

• 10.1. India Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Oncology Market

• 11.1. Japan Veterinary Oncology Market Overview
• 11.2. Japan Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Oncology Market

• 12.1. Australia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Oncology Market

• 13.1. Indonesia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Oncology Market

• 14.1. South Korea Veterinary Oncology Market Overview
• 14.2. South Korea Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Oncology Market

• 15.1. Western Europe Veterinary Oncology Market Overview
• 15.2. Western Europe Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Oncology Market

• 16.1. UK Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Oncology Market

• 17.1. Germany Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Oncology Market

• 18.1. France Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Oncology Market

• 19.1. Italy Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Oncology Market

• 20.1. Spain Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Oncology Market

• 21.1. Eastern Europe Veterinary Oncology Market Overview
• 21.2. Eastern Europe Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Oncology Market

• 22.1. Russia Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Oncology Market

• 23.1. North America Veterinary Oncology Market Overview
• 23.2. North America Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Oncology Market

• 24.1. USA Veterinary Oncology Market Overview
• 24.2. USA Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Oncology Market

• 25.1. Canada Veterinary Oncology Market Overview
• 25.2. Canada Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Oncology Market

• 26.1. South America Veterinary Oncology Market Overview
• 26.2. South America Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Oncology Market

• 27.1. Brazil Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Oncology Market

• 28.1. Middle East Veterinary Oncology Market Overview
• 28.2. Middle East Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Oncology Market

• 29.1. Africa Veterinary Oncology Market Overview
• 29.2. Africa Veterinary Oncology Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Oncology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Oncology Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Oncology Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Oncology Market Competitive Landscape
• 30.2. Veterinary Oncology Market Company Profiles
  • 30.2.1. PetCure Oncology Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Karyopharm Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Accuray Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Oncology Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim International GmbH
• 31.2. Elanco Animal Health Inc.
• 31.3. One Health Company Inc.
• 31.4. Regeneus Limited
• 31.5. VetDC Inc.
• 31.6. Pharmaust Limited
• 31.7. AdvaVet Inc.
• 31.8. Nippon Zenyaku Kogyo Company Limited
• 31.9. Rhizen Pharmaceutical SA
• 31.10. AB Science SAS
• 31.11. Siemens Healthineers AG
• 31.12. Varian Medical Systems
• 31.13. Pfizer Inc.
• 31.14. Takis Biotech GmbH
• 31.15. Qbiotics LLC

32. Global Veterinary Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Oncology Market

34. Recent Developments In The Veterinary Oncology Market

35. Veterinary Oncology Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Oncology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Oncology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Oncology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer